No significant difference with respect to baseline sensitivity for all antimicrobial agents was noted. The subjective symptom improvement rates were as follows: 1 week, 66.7%, 60.0%, 76.7% (group A, group B, group C); 4 weeks, 76.7%, 73.3%, 80.0%; after 8 weeks, 63.3%, 86.7%, 73.3% (after 8 weeks, no statistical differences were observed among these 3 groups [Fisher’s exact test]). Objective improvement rates were as follows: 1 week, 73.3%, 80.0%, 76.7%; 4 weeks, 83.3%, 86.7%, 80.0%; after 8 weeks, 66.7%, 96.7%, 76.7% (after 8 weeks, group A vs. group B; p =0.018. odds; 10.0. group A vs. group C; not statistically significant, group B vs. group C; not statistically significant [Fisher’s exact test]). Patients with ‘Blood Stasis Score of Terasawa’ of 30 points or more before treatment were 43.3 %%, 53.3%, 56.7%, and after 8 weeks, 30.0%, 0%, 36.7% (group A vs. group B; p=0.005, odds; 23.2, group A vs. group C; not statistically significant, group B vs. group C; p=0.003, odds; 21.7). No adverse events were observed in this study by prescribing KBG and CGS.